References
- USP DI, 17th Ed. Rockville 1997; Vol. 1: 714–720
- Lowes M.M.J., Caira M.R., Lötter A.P., Van Der Watt J.G. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J. Pharm. Sci. 1987; 76(9)744–752
- Behme R.J., Brooke D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J. Pharm. Sci. 1991; 80(10)986–990
- Rustichelli C., Gamberini G., Ferioli V., Gamberini M.C., Ficarra R., Tommasini S. Solid-state study of polymorphic drugs: carbamazepine. J. Pharm. Biomedical Analysis 2000; 23: 41–54
- Edwards A.D., Shekunov B.Y., Forbes R.T., Grossmann J.G., York P. Time-resolved X-ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine. J. Pharm. Sci. 2001; 90(8)1106–1114
- Levy R.H., Wilensky A.J., Anderson G.D. Carbamazepine, valproic acid, phenobarbital, and ethosuximide. Applied Pharmacokinetics. Principles of Therapeutic Drug Monitoring, 3rd Ed., W.E. Evans, J.J. Schentag, W.J. Jusko. Applied Therapeutics, Vancouver 1992; 26-1–26-29
- El-Nahhas S.A. Physico-chemical characteristics of carbamazepine-β-cyclodextrin inclusion compounds and carbamazepine-PEG solid dispersions. Pharmazie 1996; 51(12)960–963
- Brewster M.E., Anderson W.R., Meinsma D., Moreno D., Webb A.I., Pablo L., Estes K.S., Derendorf H., Bodor N., Sawchuk R., Cheung B., Pop E. Intravenous and oral pharmacokinetics evaluation of a 2-hydroxypropyl-β-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. J. Pharm. Sci. 1997; 86(3)335–339
- Giunchedi P., Conte U., La Manna A. Carbamazepine modified release dosage forms. Drug Dev. Ind. Pharm. 1991; 17(13)1753–1764
- Shah S.S., Kulkarni M.G., Mashelkar R.A. A pH dependent zero order release from glassy hydrogels: penetration vs. diffusion control. J. Controlled Release 1991; 15: 121–132
- Giunchedi P., Maggi L., Conte U., La Manna A. Linear extended release of a water-insoluble drug, carbamazepine, from erodible matrices. Int. J. Pharm. 1993; 94: 15–22
- Fresta M., Cavallaro G., Giammona G., Wehrli E., Puglisi G. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. Biomaterials 1996; 17(8)751–758
- Qadan A., Süss W. Controlled release of carbamazepine from pellets and tablets manufactured with hydroxypropyl methylcellulose. Pharmazie 2000; 55(8)628
- Ikinci G., Capan Y., Senel S., Dalkara T., Hincal A.A. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets. Pharmazie 1999; 54(2)139–141
- Vidgren P., Vidgren M., Arppe J., Hakuli T., Laine E., Paronen P. In vitro evaluation of spray-dried mucoadhesive microspheres for nasal administration. Drug Dev. Ind. Pharm. 1992; 18(5)581–597
- Giunchedi P., Torre M.L., Maggi L., Conti B., Conte U. Cellulose acetate trimellitate microspheres containing NSAIDs. Drug Dev. Ind. Pharm. 1995; 21(3)315–330
- Wulff M., Aldén M. Solid state study of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur. J. Pharm. Sci. 1999; 8: 269–281